Rockwell appoints Dr Alvin Crumbliss to scientific advisory board
This article was originally published in Scrip
Executive Summary
Rockwell Medical, a US-based biopharmaceutical company offering products and services targeting end-stage renal disease, chronic kidney disease and iron deficiency anaemia, has elected Dr Alvin Crumbliss to its scientific advisory board. He is Bishop-MacDermott family professor of chemistry at Duke University, the Dean of the faculty of arts & sciences and the Dean of Trinity College, Duke University.